BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,265.00
+65.00 (2.03%)
Last updated: May 13, 2025
-39.31%
Market Cap 26.18B
Revenue (ttm) 12.35B
Net Income (ttm) -5.40B
Shares Out 8.18M
EPS (ttm) -659.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,458
Average Volume 9,764
Open 3,260.00
Previous Close 3,200.00
Day's Range 3,210.00 - 3,300.00
52-Week Range 2,750.00 - 5,800.00
Beta 1.07
RSI 56.15
Earnings Date May 12, 2025

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 99
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.